Chapter 15. Xenotransplanation in Pharmaceutical Biotechnology
- Dr. Oliver Kayser,
- Prof. Dr. Rainer H. Müller
Published Online: 28 JAN 2005
DOI: 10.1002/3527602410.ch15
Copyright © 2004 Wiley-VCH Verlag GmbH & Co. KGaA
Book Title

Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications
Additional Information
How to Cite
Brunn, G. J. and Platt, J. L. (2005) Xenotransplanation in Pharmaceutical Biotechnology, in Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications (eds O. Kayser and R. H. Müller), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, FRG. doi: 10.1002/3527602410.ch15
Editor Information
Free University Berlin, Institute of Pharmacy, Pharmaceutical Technology, Biopharmacy & Biotechnology, Kelchstr. 31, 12169 Berlin, Germany
Publication History
- Published Online: 28 JAN 2005
- Published Print: 28 JAN 2004
ISBN Information
Print ISBN: 9783527305544
Online ISBN: 9783527602414
- Summary
- Chapter
Keywords:
- pharmaceutical biotechnology;
- xenotransplanation;
- pig as a source of tissues;
- pig as a source of organs;
- biologic response;
- immunologic responses to xenotransplantation;
- rejection;
- complement activation;
- accommodation;
- cellular mediated immune responses;
- physiologic hurdles;
- zoonosis
Summary
The Pig as a Source of Tissues and Organs for Clinical Xenotransplantation
The Biologic and Immunologic Responses to Xenotransplantation
Hyperacute Rejection
Complement Activation
Acute Vascular Rejection
Accommodation
Cellular Mediated Immune Responses
Physiologic Hurdles to Xenotransplantation
Zoonosis
A Scenario for the Clinical Application of Xenotransplantation
Acknowledgments
References
